Recursion (NASDAQ: RXRX) and Exscientia PLC (NASDAQ: EXAI) have announced that their shareholders have overwhelmingly approved the proposed combination between the two companies. The transaction is ...

That's why it's difficult for long-term investors to justify investing in the company, especially given the many attractive ...

The market trades near all-time highs with extreme valuations, driven by passive investing and questionable underlying ...

Background Adult-onset Still’s disease (AOSD) is a systemic autoinflammatory disorder lacking a gold-standard diagnostic ...

On July 4, 2026, Vitalik Buterin published the most consequential Ethereum protocol document in four years: an updated "Lean Ethereum" strawmap that commits the world's second-largest blockchain to ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...

ARK Invest bought 1.25M shares of Recursion Pharmaceuticals for $4.33M ARK added 37,075 CRISPR Therapeutics shares worth $1.97M PagerDuty was the biggest sell at $3.89M for 566,650 shares ARK also cut ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

This repository contains a set of classic algorithm problems and solutions implemented in PHP 8 and above. It is designed for anyone looking to practice or improve their algorithm skills using modern ...